Full-Time

Security and Identity Consultant

Confirmed live in the last 24 hours

RELX

RELX

1,001-5,000 employees

Provides analytics and decision tools for professionals

No salary listed

Mid, Senior

Company Historically Provides H1B Sponsorship

Hammersmith, London, UK

Category
Cybersecurity
IT & Security
Requirements
  • Bachelor’s degree in computer science, Cybersecurity, Information Technology, or a related field (or equivalent work experience)
  • Valuable experience in IAM or a similar cybersecurity role
  • Relevant certifications such as CISSP, CISM, CompTIA Security+, or Microsoft Certified: Identity and Access Administrator are preferred.
Responsibilities
  • Overall accountability for the Global Technology Operations security roadmap
  • Designing, implementing, and maintaining IAM frameworks to support organisational needs
  • Developing and enforcing IAM policies in alignment with organisational standards and regulatory requirements
  • Generating and presenting IAM-related audit reports to leadership and stakeholders
  • Collaborating with the CISO office to identify, assess, and mitigate potential vulnerabilities
  • Respond to security incidents involving identity or access breaches
  • Ensuring compliance with role-based access control (RBAC) and least-privilege principles.
Desired Qualifications
  • Knowledge of security standards, technology opportunities, managing potential security incidents and current cyber threats
  • Proficiency with IAM tools (e.g. Saviynt)
  • Knowledge of authentication protocols such as LDAP
  • Familiarity with scripting and automation (e.g., PowerShell, Python)
  • Experience with cloud platforms (AWS, Azure, OCI) and securing cloud environments
  • Strong analytical and problem-solving abilities
  • Excellent communication and collaboration skills
  • Ability to work effectively in a fast-paced, dynamic environment.

RELX provides information-based analytics and decision tools tailored for professional and business customers across various sectors. The company operates in four key areas: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products utilize extensive data and analytics to assist clients, such as researchers, healthcare professionals, legal practitioners, and business executives, in making informed decisions and enhancing productivity. RELX's subscription-based business model ensures a consistent revenue stream, while it also earns income through transactional sales and advertising. A distinguishing feature of RELX is its commitment to corporate responsibility, focusing on diversity, social justice, and sustainable development, actively supporting the United Nations' Sustainable Development Goals through its offerings.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1894

Simplify Jobs

Simplify's Take

What believers are saying

  • ScienceDirect AI reduces research time, enhancing productivity for researchers globally.
  • Inter Airport Southeast Asia 2025's success highlights growth opportunities in the exhibitions segment.
  • Partnership with Conexiant expands digital solutions in healthcare, boosting market reach.

What critics are saying

  • AI competition may impact RELX's market share if innovation lags.
  • Sustainability demands could increase operational costs for RELX's Exhibitions segment.
  • Growing demand for exhibitions in Asia may strain RELX's resources if not scaled.

What makes RELX unique

  • RELX offers a subscription-based model ensuring steady recurring revenue streams.
  • The company integrates extensive data analytics for informed decision-making across industries.
  • RELX actively supports UN Sustainable Development Goals through its products and partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Family Planning Benefits

Health Savings Account/Flexible Spending Account

Flexible Work Hours

Remote Work Options

Company News

PharmiWeb
May 7th, 2025
Elsevier Adds Half A Million Records From Clinicaltrials.Gov To Embase, Enabling A Seamless Search Experience In The World’S Most Comprehensive Biomedical Database

London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Researchers will be able to conduct more comprehensive evidence and literature searches while having the confidence they will never miss important updates relevant to their drug, therapy, or medical device. Clinical trials data is a vital component of biomedical literature search, helping pharmaceutical and medical device companies stay informed about the latest scientific advancements, regulatory requirements, and competitive insights to support evidence-based decision-making. However, gathering data from multiple sources is currently prone to errors and is time-consuming, such as the duplication of search results, which slows research and regulatory processes. As new therapies and devices are developed and RD organizations seek collaborative partners, they must undertake thorough searches and justifications of evidence

PR Newswire
May 6th, 2025
Elsevier Adds Half A Million Records From Clinicaltrials.Gov To Embase, Enabling A Seamless Search Experience In The World'S Most Comprehensive Biomedical Database

Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safetyLONDON, May 6, 2025 /PRNewswire/ -- Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Researchers will be able to conduct more comprehensive evidence and literature searches while having the confidence they will never miss important updates relevant to their drug, therapy, or medical device.Clinical trials data is a vital component of biomedical literature search, helping pharmaceutical and medical device companies stay informed about the latest scientific advancements, regulatory requirements, and competitive insights to support evidence-based decision-making. However, gathering data from multiple sources is currently prone to errors and is time-consuming, such as the duplication of search results, which slows research and regulatory processes. As new therapies and devices are developed and R&D organizations seek collaborative partners, they must undertake thorough searches and justifications of evidence. This process becomes challenging when data must be sourced from differing platforms, and regulatory and compliance requirements continue to evolve.The addition of ClinicalTrials.gov data to Embase will improve researcher workflows by making clinical data searchable within Embase's user-friendly interface

ACN Newswire
Apr 21st, 2025
Inter Airport Southeast Asia 2025 Sets A New Benchmark For Attendance, Marking Its 8Th Edition In Singapore With Record-Breaking Participation

Trade attendees gathered in anticipation for the opening day of IASEA 2025. SINGAPORE, Apr 21, 2025 - (ACN Newswire) - The 8th edition of inter airport Southeast Asia (IASEA) was held in Singapore from 25-27 March 2025. Spanning across 6,259 sqm of exhibition space, the airport exhibition and conference brought together 3,621 industry trade professionals from 53 countries and regions, and featured 134 exhibiting companies including pavilions representing Germany, Italy, Japan and Singapore. The event saw a 43% increase in exhibitor size and a 15.6% rise in attendee numbers, underscoring the rising significance of IASEA as a platform for productive discussions. The event's achievement is also attributed to the increasing demands of operators and the rapid development and expansion of airports in Asia

PR Newswire
Apr 1st, 2025
Lexisnexis Risk Solutions Expands Leadership Team With Fraud Prevention Expert Glenn Prager

Veteran Fraud Prevention Leader Joins LexisNexis Risk Solutions to Strengthen Program Integrity and Protect Public FundsWASHINGTON, April 1, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions today announced the addition of Glenn Prager as Executive Director of Government Risk Solutions, reinforcing its commitment to safeguarding the integrity of our nation's critical social safety nets. Prager, a proven leader in combating fraud, waste, and abuse, brings over two decades of public and private sector experience leveraging data, analytics, and technology to ensure benefits reach those who truly need them. Glenn will work across key markets, including the U.S. Department of Health and Human Services, State and Local Medicaid Departments, and Inspector General Offices."With today's rapidly evolving fraud landscape, ensuring the integrity of federal and state benefit programs is more critical than ever," said Haywood Talcove, CEO of LexisNexis Risk Solutions – Government. "Glenn Prager's unparalleled expertise in program integrity, forensic auditing, and multi-jurisdictional fraud investigations makes him an invaluable addition to our team. His leadership will strengthen our ability to support government agencies in their mission to protect public funds, while ensuring those in need receive essential services."Prager's career has been defined by his dedication to strengthening government oversight, developing anti-fraud strategies, and enhancing compliance across Medicare, Medicaid, and other federally funded programs

ACN Newswire
Mar 25th, 2025
Asia'S Airports Take The Lead At Inter Airport Southeast Asia 2025 Kicks Off The Conference, Driving Conversations On The Future Of Airport Operations And Passenger Experience

Set to welcome 4,000 airport professionals, 150 international exhibitors, 4 dynamic pavilions, and 53 speakers from 66 countries and regions, IASEA 2025 is poised to shape the future of airport operations and passenger experience throughout the next 3 days. SINGAPORE, Mar 25, 2025 - (ACN Newswire) - The much-anticipated inter airport Southeast Asia (IASEA) 2025 has officially opened today at Marina Bay Sands, Singapore, bringing together key airport industry stakeholders, global solution providers, and leading experts to shape the future of airport operations and passenger experience. Themed “Airport Operations for Tomorrow”, conversations surrounding these topics are especially crucial as the aviation industry is witnessing rapid transformation and projected global passenger traffic to reach 19.5 billion by 2042